US approves first-of-kind device to treat obesity
A first-of-its-kind implant to treat obesity that curbs the appetite by electrically stimulating stomach nerves has been approved in the US.
The Maestro Rechargeable System is approved to treat patients aged 18 and older who have not been able to lose
weight with a weight loss programme, and who have a body mass index of 35 to 45 with at least one other obesity-related
condition, such as type 2 diabetes.
The US Food and Drug Administration (FDA) approved the implant for certain obese adults, the first weight loss